Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Revenue: 2010-2025

Historic Revenue for Sunshine Biopharma (SBFM) over the last 13 years, with Sep 2025 value amounting to $9.4 million.

  • Sunshine Biopharma's Revenue rose 11.64% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year increase of 13.24%. This contributed to the annual value of $34.9 million for FY2024, which is 44.75% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Revenue of $9.4 million as of Q3 2025, which was up 0.07% from $9.4 million recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Revenue peaked at $9.6 million during Q4 2024, and registered a low of $40,058 during Q1 2021.
  • In the last 3 years, Sunshine Biopharma's Revenue had a median value of $8.4 million in 2024 and averaged $7.9 million.
  • Data for Sunshine Biopharma's Revenue shows a peak YoY surged of 4,528.68% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Sunshine Biopharma's Revenue stood at $85,118 in 2021, then skyrocketed by 4,528.68% to $3.9 million in 2022, then skyrocketed by 94.94% to $7.7 million in 2023, then grew by 24.93% to $9.6 million in 2024, then grew by 11.64% to $9.4 million in 2025.
  • Its Revenue stands at $9.4 million for Q3 2025, versus $9.4 million for Q2 2025 and $8.9 million for Q1 2025.